$JNJ Company News Ebola-nation travelers to U.
Post# of 72745
Posted On: 10/23/2014 1:46:21 PM
$JNJ Company News
Ebola-nation travelers to U.S. to be watched 21 days 3:04 p.m. Oct. 22, 2014 - Russ Britt
Johnson & Johnson to begin testing Ebola vaccine in January 9:14 a.m. Oct. 22, 2014 - Jonathan D. Rockoff
A possible new Ebola vaccine from Johnson&Johnson 4:32 a.m. Oct. 22, 2014 - MarketWatch
Fighting Ebola though investing: one firm’s approach 6:42 p.m. Oct. 21, 2014 - Wallace Witkowski
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
Updates, advisories and surprises 5:31 p.m. Oct. 14, 2014 - MarketWatch
Delta, Citigroup gain; J.P. Morgan, Wells Fargo slide following results 10:58 a.m. Oct. 14, 2014 - Sue Chang
Newscast: Google launches same-day delivery 9:58 a.m. Oct. 14, 2014 - MarketWatch
All the reasons to sell this market are enough to draw a guy in 9:23 a.m. Oct. 14, 2014 - Shawn Langlois
J&J's earnings jump on higher drug sales 8:12 a.m. Oct. 14, 2014 - MarketWatch.com
Johnson & Johnson shares gain after profit beat, raised outlook 7:59 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson shares up 1% premarket after Q3 results 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson ups 2014 EPS outlook to $5.92-$5.97 from $5.85-$5.92 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 net EPS $1.66 vs. $1.04 a year ago 7:49 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales of $18.5 bln vs. FactSet consensus $18.44 bln 7:48 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales up 5.1% from last year to $18.5 bln 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 adj. EPS $1.50 vs. FactSet consensus $1.45 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
What to expect from Johnson & Johnson’s earnings 7:09 a.m. Oct. 14, 2014 - Tomi Kilgore
The market in a minute: Schizophrenic action 12:40 p.m. Oct. 13, 2014 - The Trading Deck
Earnings under pressure from stronger U.S. dollar 5:30 a.m. Oct. 12, 2014 - Wallace Witkowski
3M the Cash Generation Machine in the Industrials Segment 11:53 a.m. Today - GuruFocus.com
My Dividend Stocks Aren't For Sale 5:04 a.m. Today - Seeking Alpha
'Fast Money' Recap: Look to Exxon Mobil as Oil Continues Lower 5:00 a.m. Today - TheStreet.com
The New Nifty Fifty, Part 2: Dividend Growth Investing's Greatest Hits 10:15 p.m. Oct. 22, 2014 - Seeking Alpha
Time In The Market Is More Important Than Timing The Market 8:57 p.m. Oct. 22, 2014 - Seeking Alpha
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Goldman Sachs Group (GS) Lags 4:30 p.m. Oct. 22, 2014 - TheStreet.com
The Income Buffer In Relation To Price Declines 2:23 p.m. Oct. 22, 2014 - Seeking Alpha
The Bloggers' Dividend Growth Portfolio: Popular Dividend Growth Stocks Trading On U.S. Exchanges 2:18 p.m. Oct. 22, 2014 - Seeking Alpha
Pharmacyclics Up on Label Expansion Efforts for Imbruvica - Analyst Blog 1:54 p.m. Oct. 22, 2014 - Zacks.com
Dividend Aristocrats In Focus Part 24: Consolidated Edison 1:43 p.m. Oct. 22, 2014 - GuruFocus.com
3 Drugs Stocks Pushing The Industry Higher 1:03 p.m. Oct. 22, 2014 - TheStreet.com
EC approves ulcerative colitis med 11:31 a.m. Oct. 22, 2014 - Seeking Alpha
JNJ and GSK Working on Ebola Vaccines 9:42 a.m. Oct. 22, 2014 - InvestorPlace.com
J&J to Test Ebola Vaccine in January 8:45 a.m. Oct. 22, 2014 - The Wall Street Journal Interactive Edition
Why Johnson & Johnson (JNJ) Stock Is Higher Today 7:45 a.m. Oct. 22, 2014 - TheStreet.com
October 22 Premarket Briefing: 10 Things You Should Know 6:36 a.m. Oct. 22, 2014 - TheStreet.com
Wall Street Breakfast: Bank Of England Keeps Rates Low 6:32 a.m. Oct. 22, 2014 - Seeking Alpha
Dispatches: Ebola News Digest 1:53 a.m. Oct. 22, 2014 - The Wall Street Journal Interactive Edition
Gilead Sciences: Pricing, Politics And Profits 3:23 p.m. Oct. 21, 2014 - Seeking Alpha
Celgene Reports More Good Crohn's Disease Data 10:32 a.m. Oct. 21, 2014 - Investors Business Daily
Axxess Pharma Retains Natural Products Consulting Institute "NPCI" for Health Canada Approval of TapouT High Potency Omega-3 Fish Oil and TapouT Turbo Blend Protein Powder 8:02 a.m. Today - Marketwired
Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN(R) for Additional Infectious Disease Targets 5:47 p.m. Oct. 22, 2014 - Thomson Reuters ONE
TransPerfect Princeton Opens for Business 9:45 a.m. Oct. 22, 2014 - BusinessWire - BZX
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 2:06 a.m. Oct. 22, 2014 - GlobeNewswire
Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production 2:02 a.m. Oct. 22, 2014 - PR Newswire - PRF
Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Development Corporation 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Vaccines, Medical Oxygen, and Helping the Ebola Crisis 1:47 p.m. Oct. 21, 2014 - ACCESSWIRE
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Post-Earnings Insight - Johnson and Johnson 9:05 a.m. Oct. 16, 2014 - PR Newswire - PRF
Tetra Discovery Partners Announces Additional Financing and Formation of Scientific Advisory Board 8:03 a.m. Oct. 16, 2014 - PR Newswire - PRF
Aduro Expands Collaboration with Johnson & Johnson Innovation and Janssen for Lung Cancer Immunotherapies 8:01 a.m. Oct. 16, 2014 - BusinessWire - BZX
Spine Wave Announces Addition to the Executive Management Team 8:01 a.m. Oct. 16, 2014 - Marketwired
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2014 7:45 a.m. Oct. 16, 2014 - PR Newswire - PRF
Johnson & Johnson Family of Consumer Companies Turns Brands Purple in Support of Spirit Day 9:00 a.m. Oct. 15, 2014 - PR Newswire - PRF
China Diagnostic Reagent Industry Report, 2013-2016 6:53 p.m. Oct. 14, 2014 - PR Newswire - PRF
Critical Alerts For Digital River, Cheniere Energy, Intel, US Ecology Inc and Johnson & Johnson Released By InvestorsObserver 9:31 a.m. Oct. 13, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
Alios BioPharma Presented Positive Results of Its Anti-RSV Nucleoside Analog AL-8176 in a Phase 2 Challenge Study in Adults Infected With Respiratory Syncytial Virus (RSV) at IDWeek 8:31 a.m. Oct. 13, 2014 - Marketwired
SHPE Presents 2014 STAR Award Company of the Year to Johnson & Johnson and Government Agency of the Year to U.S. Army 12:00 p.m. Oct. 8, 2014 - PR Newswire - PRF
Ebola-nation travelers to U.S. to be watched 21 days 3:04 p.m. Oct. 22, 2014 - Russ Britt
Johnson & Johnson to begin testing Ebola vaccine in January 9:14 a.m. Oct. 22, 2014 - Jonathan D. Rockoff
A possible new Ebola vaccine from Johnson&Johnson 4:32 a.m. Oct. 22, 2014 - MarketWatch
Fighting Ebola though investing: one firm’s approach 6:42 p.m. Oct. 21, 2014 - Wallace Witkowski
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
Updates, advisories and surprises 5:31 p.m. Oct. 14, 2014 - MarketWatch
Delta, Citigroup gain; J.P. Morgan, Wells Fargo slide following results 10:58 a.m. Oct. 14, 2014 - Sue Chang
Newscast: Google launches same-day delivery 9:58 a.m. Oct. 14, 2014 - MarketWatch
All the reasons to sell this market are enough to draw a guy in 9:23 a.m. Oct. 14, 2014 - Shawn Langlois
J&J's earnings jump on higher drug sales 8:12 a.m. Oct. 14, 2014 - MarketWatch.com
Johnson & Johnson shares gain after profit beat, raised outlook 7:59 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson shares up 1% premarket after Q3 results 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson ups 2014 EPS outlook to $5.92-$5.97 from $5.85-$5.92 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 net EPS $1.66 vs. $1.04 a year ago 7:49 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales of $18.5 bln vs. FactSet consensus $18.44 bln 7:48 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales up 5.1% from last year to $18.5 bln 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 adj. EPS $1.50 vs. FactSet consensus $1.45 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
What to expect from Johnson & Johnson’s earnings 7:09 a.m. Oct. 14, 2014 - Tomi Kilgore
The market in a minute: Schizophrenic action 12:40 p.m. Oct. 13, 2014 - The Trading Deck
Earnings under pressure from stronger U.S. dollar 5:30 a.m. Oct. 12, 2014 - Wallace Witkowski
3M the Cash Generation Machine in the Industrials Segment 11:53 a.m. Today - GuruFocus.com
My Dividend Stocks Aren't For Sale 5:04 a.m. Today - Seeking Alpha
'Fast Money' Recap: Look to Exxon Mobil as Oil Continues Lower 5:00 a.m. Today - TheStreet.com
The New Nifty Fifty, Part 2: Dividend Growth Investing's Greatest Hits 10:15 p.m. Oct. 22, 2014 - Seeking Alpha
Time In The Market Is More Important Than Timing The Market 8:57 p.m. Oct. 22, 2014 - Seeking Alpha
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Goldman Sachs Group (GS) Lags 4:30 p.m. Oct. 22, 2014 - TheStreet.com
The Income Buffer In Relation To Price Declines 2:23 p.m. Oct. 22, 2014 - Seeking Alpha
The Bloggers' Dividend Growth Portfolio: Popular Dividend Growth Stocks Trading On U.S. Exchanges 2:18 p.m. Oct. 22, 2014 - Seeking Alpha
Pharmacyclics Up on Label Expansion Efforts for Imbruvica - Analyst Blog 1:54 p.m. Oct. 22, 2014 - Zacks.com
Dividend Aristocrats In Focus Part 24: Consolidated Edison 1:43 p.m. Oct. 22, 2014 - GuruFocus.com
3 Drugs Stocks Pushing The Industry Higher 1:03 p.m. Oct. 22, 2014 - TheStreet.com
EC approves ulcerative colitis med 11:31 a.m. Oct. 22, 2014 - Seeking Alpha
JNJ and GSK Working on Ebola Vaccines 9:42 a.m. Oct. 22, 2014 - InvestorPlace.com
J&J to Test Ebola Vaccine in January 8:45 a.m. Oct. 22, 2014 - The Wall Street Journal Interactive Edition
Why Johnson & Johnson (JNJ) Stock Is Higher Today 7:45 a.m. Oct. 22, 2014 - TheStreet.com
October 22 Premarket Briefing: 10 Things You Should Know 6:36 a.m. Oct. 22, 2014 - TheStreet.com
Wall Street Breakfast: Bank Of England Keeps Rates Low 6:32 a.m. Oct. 22, 2014 - Seeking Alpha
Dispatches: Ebola News Digest 1:53 a.m. Oct. 22, 2014 - The Wall Street Journal Interactive Edition
Gilead Sciences: Pricing, Politics And Profits 3:23 p.m. Oct. 21, 2014 - Seeking Alpha
Celgene Reports More Good Crohn's Disease Data 10:32 a.m. Oct. 21, 2014 - Investors Business Daily
Axxess Pharma Retains Natural Products Consulting Institute "NPCI" for Health Canada Approval of TapouT High Potency Omega-3 Fish Oil and TapouT Turbo Blend Protein Powder 8:02 a.m. Today - Marketwired
Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN(R) for Additional Infectious Disease Targets 5:47 p.m. Oct. 22, 2014 - Thomson Reuters ONE
TransPerfect Princeton Opens for Business 9:45 a.m. Oct. 22, 2014 - BusinessWire - BZX
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 2:06 a.m. Oct. 22, 2014 - GlobeNewswire
Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production 2:02 a.m. Oct. 22, 2014 - PR Newswire - PRF
Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Development Corporation 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Vaccines, Medical Oxygen, and Helping the Ebola Crisis 1:47 p.m. Oct. 21, 2014 - ACCESSWIRE
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Post-Earnings Insight - Johnson and Johnson 9:05 a.m. Oct. 16, 2014 - PR Newswire - PRF
Tetra Discovery Partners Announces Additional Financing and Formation of Scientific Advisory Board 8:03 a.m. Oct. 16, 2014 - PR Newswire - PRF
Aduro Expands Collaboration with Johnson & Johnson Innovation and Janssen for Lung Cancer Immunotherapies 8:01 a.m. Oct. 16, 2014 - BusinessWire - BZX
Spine Wave Announces Addition to the Executive Management Team 8:01 a.m. Oct. 16, 2014 - Marketwired
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2014 7:45 a.m. Oct. 16, 2014 - PR Newswire - PRF
Johnson & Johnson Family of Consumer Companies Turns Brands Purple in Support of Spirit Day 9:00 a.m. Oct. 15, 2014 - PR Newswire - PRF
China Diagnostic Reagent Industry Report, 2013-2016 6:53 p.m. Oct. 14, 2014 - PR Newswire - PRF
Critical Alerts For Digital River, Cheniere Energy, Intel, US Ecology Inc and Johnson & Johnson Released By InvestorsObserver 9:31 a.m. Oct. 13, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
Alios BioPharma Presented Positive Results of Its Anti-RSV Nucleoside Analog AL-8176 in a Phase 2 Challenge Study in Adults Infected With Respiratory Syncytial Virus (RSV) at IDWeek 8:31 a.m. Oct. 13, 2014 - Marketwired
SHPE Presents 2014 STAR Award Company of the Year to Johnson & Johnson and Government Agency of the Year to U.S. Army 12:00 p.m. Oct. 8, 2014 - PR Newswire - PRF
(0)
(0)